Skip to main content
Caplight Logo









Abiochem Biotechnology

Abiochem Biotechnology

Private
ShanghaiHealthcare & Life Scienceshttps://abiochem.com/

Last Round

Strategic

Jul 24, 2025

Total Funding Raised

$124.2M

Company Overview

Abiochem Biotechnology is a synthetic biology company that develops and manufactures chemical and biological products for the pharmaceutical, agricultural, and food industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Smart Manufacturing, Drug Discovery, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

synthetic biologybiomanufacturingsynbioCDMOcontract manufacturingenzyme engineeringactive pharmaceutical ingredientsAPIindustrial fermentationcell factorybioprocess engineeringCROcontract researchgreen chemistrybio-based ingredients

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Abiochem Biotechnology Comparables

Compare Abiochem Biotechnology with similar companies based on industry and business-model similarity.

Abiochem Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bota Biosciences
81%
上海依诺基科生物技术有限公司
77%
Tidetron Bioworks
77%

Abiochem Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJul 24, 2025
Series CApr 30, 2021
Series BNov 30, 2020
Series AApr 3, 2019
AngelJun 28, 2018

Abiochem Biotechnology Investors

Notable investors and investment history

Abiochem Biotechnology investors
InvestorRounds
TemasekSeries C
招银国际金融有限公司Series C
Addor CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2025

    $63M raised in strategic round.

  • Apr 30, 2021

    $46.3M round led by Temasek

Abiochem Biotechnology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Abiochem Biotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Abiochem Biotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Year Founded2015
Last FundingJul 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?